| Show Number |
Air Week |
Title |
Program Description |
| SHOW #107 |
July 13, 1997 |
Gene Therapy |
Scientists at the University of Pennsylvania are attempting gene therapy
as a treatment for cystic fibrosis. They have developed a new "vector," which is
the vehicle used to deliver altered, repaired genes to human cells, typically a virus. In
the past, such attempts have either been rejected by the body, or the positive effects of
the therapy have dwindled over time, meaning that the new "normal" cells were
not growing and spreading, and replacing the diseased cells. The Penn team is hopeful that
this new vector will change all that. Cystic Fibrosis is a leading candidate for gene
therapy because it is the result of a single mutated gene. Many other diseases stem from
multiple mutated genes, rendering gene therapy much more difficult. CONTACT: Frank Hoke,
Science Writer, University of Pennsylvania, 215-662-2560 |
| |
|
BREAKTHROUGH PROFILES: Elsie Booker |
Elsie Booker is the proprietor of Patterson's Mill Country Store in
Durham, NC. Before her retirement, she was a registered pharmacists, one of the first
women in North Carolina to pursue that career. At her store, she has rooms designed to
accurately recreate an old pharmacy, and an old doctor's office. Her collection of
pharmaceutical and medical memorabilia is extensive, and is on display at the store.
CONTACT: Elsie Booker, Patterson's Mill Country Store, 919-493-8149 |
| |
|
Gene Chip |
This story delineates new technology that has been developed for the
analysis of genes, specifically the sequencing of genetic material. This analysis has been
miniaturized to the point that it can be done on a chip, which actually resembles a
computer chip. Up to 400,000 experiments can now be put on a single chip. CONTACT:
Affymetrix Corp., Kenneth J. Nussbacher, CFO, 408-522-6000 |
| |
|
Questionable Medical Devices |
A brief piece in which we pay a visit to the Museum of Questionable
Medical Devices in Minneapolis, curated by collector and enthusiast Bob McCoy. We will
occasionally feature McCoy showing us some of the more unusual and interesting pieces in
his renowned collection. |
| |
|
Brain Bank |
We visit the Brain Bank at Minnesota's St. Paul-Ramsey Medical Center, in
which pathologists study the mysteries of the human brain, using brains donated to
science. The researchers have discovered a potentially important pathway for medications
to reach the brain, being delivered through the nose and up the olfactory pathway. This
route bypasses the so-called "blood/brain barrier," which is a sheath
surrounding the brain that is designed to keep toxins out of the brain. Unfortunately, the
barrier also blocks most drugs from getting into the brain in sufficient doses to be
therapeutic. This discovery could have profound implications for improved delivery of
drugs to the brain. CONTACT: Dr. William Frey, St. Paul-Ramsey Medical Ctr., 612-228-8323 |
| |
|
|
|
| SHOW #108 |
July 20, 1997 |
X Chromosome |
Researchers at Washington University at St. Louis have succeeded in
generating a high-resolution map of the human X chromosome. This achievement is a
significant step forward in the world-wide effort to map the entire human genome. The X
chromosome is particularly important because many of the inherited diseases suffered by
males stem from a genetic mutation somewhere along the X chromosome. The milestone could
ultimately lead to new tests for genetic diseases, and new forms of gene therapy for those
diseases. CONTACT: Washington University School of Medicine, Joni Westerhous, Office of
Medical Public Affairs, 314-286-0100 |
| |
|
GENE WATCH |
The first installment of a new recurring feature on BreakThrough designed
to keep viewers abreast of the ongoing discovery and identification of significant human
genes. In this edition, we survey the Human Genome Project, the massive world-wide effort
to map the entire human genome. When this project is complete, it will be a landmark
achievement in science, and is expected to usher in a new era in medicine. CONTACT:
National Human Genome Research Institute, 301-402-8564 or Website:http://www.nhgri.nih.gov/NEWS/news.html |
| |
|
Sudden Cardiac Death |
Sudden cardiac death is one of our leading killers, and all too often it
strikes without any warning, in people who have no apparent risk factors. Now, a team of
researchers at MIT has discovered a previously unrecognized marker, or warning sign, for
sudden cardiac death. It's called T-Wave Alternans, and it can be detected by a newly
developed device known as a "super ECG." This device is one thousand times more
sensitive than a standard ECG, and is capable of picking up this extremely subtle warning
sign. When people with this marker have been identified, they can be given a tiny
battery-operated device called a cardiac defibrillator. The defibrillator is implanted in
the patient, senses when the heart begins to beat out of control, and sends an electrical
impulse out, re-set the heart's rhythm. CONTACT: Jeffrey Arnold, President & CFO,
Cambridge Heart, 617-271-1200 or Elizabeth Thompson, Science Writer, MIT News Office,
617-253-2700 |
| |
|
FUTUREX: AngioJet |
The AngioJet is a device that may soon replace bypass surgery and
side-effect-prone drug therapies for arterial blockage. It is essentially an
"arterial vacuum cleaner," in that it is fed to the clot site via a catheter,
and essentially sucks the clot away. CONTACT: Possis Medical, Inc. Minneapolis, MN
1-800-810-7677 |
| |
|
Men's & Women's Brains |
Reuban & Raquel Gur are both psychologists at the University of
Pennsylvania Medical Center. Together, through a combination of behavioral tests and
Positron Emission Tomography (PET) brain imaging, they have discovered some significant
differences between the brains of men and women. It seems that men start out with larger
brains, but lose brain tissue with aging at a rate three times faster than women, and that
loss begins much younger. Thus, they tend to work their remaining brain tissue at higher
metabolic rates. This can in turn accelerate brain cell loss, and it's suspected that this
might be a contributing factor to the lower average life expectancy of men. Women, on the
other hand, also lose brain tissue, but the loss starts later in life, and their brain
activity gradually slows roughly in proportion to the tissue loss. The Gurs also suspect
that their findings might shed light on some of the well-documented behavioral differences
between men and women. CONTACT: Frank Hoke, Science Writer, University of Pennsylvania,
215-662-2560 |
| |
|
|
|
| SHOW #109 |
July 27, 1997 |
HIV Resistance |
It's been one of the ongoing mysteries of the HIV/AIDS epidemic that
there seems to be a small number of people who, although exposed to the HIV virus, never
contract the disease. Now, scientists at the University of Pennsylvania have identified a
genetic mutation which shuts off a specific cell receptor. This effect apparently inhibits
the ability of the virus to invade the cell, rendering the person either somewhat
resistant to the disease (if the carrier has a single mutation in the DNA) or almost
completely resistant (if the carrier has two copies of the mutation in the DNA). These
findings may have implications in the future for new treatments, as researchers look for
ways to confer this resistance upon people who don't carry it naturally. CONTACT: Frank
Hoke, Science Writer, University of Pennsylvania, 215-662-2560 |
| |
|
BREAKTHROUGHS IN HISTORY: In Vitro Fertilization |
A brief profile of the first use of this breakthrough in human
reproduction, which took place in 1980 at the Jones Institute at Eastern Virginia Medical
School in Norfolk. The Jones Institute continues to be a leader in the field. CONTACT:
Jones Institute for Reproductive Medicine, Norfolk, VA, 757-446-7100 |
| |
|
Bone Marrow |
A new technology called the Aastrom Cell Reproduction System now, for the
first time, allows the growth of bone marrow cells outside the body. This is potentially a
major step in the field of bone marrow transplants, allowing a much smaller sample to be
taken from the donor. Presently, bone marrow donation is an arduous, demanding process,
and this development could make it much easier. Also, in patients who must donate their
own marrow because a suitable matching outside donor cannot be located, the smaller sample
reduces the risk of contamination by cancer cells. CONTACT: Mike Maggio, Director of Media
Relations, Loyola University Medical Center, 708-216-6700 |
| |
|
BREAKTHOUGH PROFILES: Dr. Irwin Fridovich |
Duke University biochemist Dr. Irwin Fridovich discovered one of the keys
to the aging process - so-called "free radicals." These molecules are toxic
by-products of the body's metabolic process of turning food into energy. They roam the
body and kill cells. Fridovich also discovered that the body has a natural antidote for
free radicals called oxide dismutase. But as the free radicals do their damage over time,
the human body ages. CONTACT: Duke University Medical Center, Office of Public Affairs,
919-684-4148 |
| |
|
Photon Knife |
This is a form of brain surgery that does not involve an incision. Highly
targeted radiation, X-rays in this case, are focused on a specific area of the brain, and
destroy the target, sparing surrounding normal brain tissue. This computer-aided technique
has been used for years as one method of treating brain tumors or lesions. Now, it's being
used experimentally as an epilepsy treatment. CONTACT: John Howser, Media Director,
Vanderbilt University Medical Center, 615-322-4747 |
Back

© 1998 BTPG.
Your feedback and suggestions are welcome! Please e-mail us by clicking on the mailbox
icon. |
 |
|